Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 198

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students

Open access
Maier, Larissa J., Liechti, Matthias E., Herzig, Fiona, Schaub, Michael P. · 2013 · PLoS ONE

Abstract

BACKGROUND: Neuroenhancement is the use of substances by healthy subjects to enhance mood or cognitive function. The prevalence of neuroenhancement among Swiss university students is unknown. Investigating the prevalence of neuroenhancement among students is important to monitor problematic use and evaluate the necessity of prevention programs. STUDY AIM: To describe the prevalence of the use of prescription medications and drugs of abuse for neuroenhancement among Swiss university students. METHOD: In this cross-sectional study, students at the University of Zurich, University of Basel, and Swiss Federal Institute of Technology Zurich were invited via e-mail to participate in an online survey. RESULTS: A total of 28,118 students were contacted, and 6,275 students completed the survey. Across all of the institutions, 13.8% of the respondents indicated that they had used prescription drugs (7.6%) or drugs of abuse including alcohol (7.8%) at least once specifically for neuroenhancement. The most frequently used prescription drugs for neuroenhancement were methylphenidate (4.1%), sedatives (2.7%), and beta-blockers (1.2%). Alcohol was used for this purpose by 5.6% of the participants, followed by cannabis (2.5%), amphetamines (0.4%), and cocaine (0.2%). Arguments for neuroenhancement included increased learning (66.2%), relaxation or sleep improvement (51.2%), reduced nervousness (39.1%), coping with performance pressure (34.9%), increased performance (32.2%), and experimentation (20%). Neuroenhancement was significantly more prevalent among more senior students, students who reported higher levels of stress, and students who had previously used illicit drugs. Although "soft enhancers", including coffee, energy drinks, vitamins, and tonics, were used daily in the month prior to an exam, prescription drugs or drugs of abuse were used much less frequently. CONCLUSIONS: A significant proportion of Swiss university students across most academic disciplines reported neuroenhancement with prescription drugs and drugs of abuse. However, these substances are rarely used on a daily basis and more sporadically used prior to exams.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0077967

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 36

  1. E Hildt, 2011, Pharmacological neuroenhancement: information and acceptance among students, Nervenheilkunde, 30, 833, 10.1055/s-0038-1628433 · doi:10.1055/s-0038-1628433
  2. AG Franke, 2011, Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany, Pharmacopsychiatry, 44, 60, 10.1055/s-0030-1268417 · DOI · Paper page
  3. M Kordt, 2009, DAK Gesundheitsreport 2009, Hamburg
  4. C Normann, 2008, Neuroenhancement: status quo and perspectives, Eur Arch Psychiatry Clin Neurosci, 258 Suppl 5, 110, 10.1007/s00406-008-5022-2 · DOI
  5. Eckhardt A, Bachmann A, Marti M, Rütsche B, Telser H (2011) Human enhancement. Zürich: vdf Hochschulverlag. doi:10.3218/3404-2. · DOI
  6. H Greely, 2008, Towards responsible use of cognitive-enhancing drugs by the healthy, Nature, 456, 702, 10.1038/456702a · DOI · Paper page
  7. B Maher, 2008, Poll results: look who's doping, Nature, 452, 674, 10.1038/452674a · DOI · Paper page
  8. AM Arria, 2008, Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use, Pharmacotherapy, 28, 156, 10.1592/phco.28.2.156 · DOI · Paper page
  9. Repantis D (2009) Die Wirkung von Psychopharmaka bei Gesunden. In: Wienke A, Eberbach W, Kramer HJ, Janke K, editors. Die Verbesserung des Menschen. Tatsächliche und rechtliche Aspekte der wunscherfüllenden Medizin. Berlin Heidelberg: Springer. pp. 63–68. · doi:10.1007/978-3-642-00883-2_5
  10. BB Quednow, 2010, Ethics of neuroenhancement: a phantom debate, BioSocieties, 5, 153, 10.1057/biosoc.2009.13 · DOI
  11. H Förstl, 2009, [Neuro-enhancement. Brain doping], Der Nervenarzt, 80, 840
  12. SE McCabe, 2005, Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey, Addiction, 100, 96, 10.1111/j.1360-0443.2005.00944.x · DOI · Paper page
  13. B Sahakian, 2007, Professor's little helper, Nature, 450, 1157, 10.1038/4501157a · DOI · Paper page
  14. KB Kaloyanides, 2007, Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants, Pharmacotherapy, 27, 666, 10.1592/phco.27.5.666 · DOI · Paper page
  15. AD DeSantis, 2008, Illicit use of prescription ADHD medications on a college campus: a multimethodological approach, J American Coll Health, 57, 315, 10.3200/JACH.57.3.315-324 · DOI · Paper page
  16. S Sussman, 2006, Misuse of “study drugs”: prevalence, consequences, and implications for policy, Subst Abuse Treat Prev Policy, 1, 15, 10.1186/1747-597X-1-15 · DOI
  17. S Mache, 2012, Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences, Wiener Medizinische Wochenschrift, 162, 262, 10.1007/s10354-012-0115-y · DOI
  18. G Franke a, 2010, [Pharmacological neuroenhancement and brain doping: chances and risks], Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 53, 853
  19. P Eickenhorst, 2012, Neuroenhancement among German university students: motives, expectations, and relationship with psychoactive lifestyle drugs, J Psychoactive Drugs, 44, 418, 10.1080/02791072.2012.736845 · DOI
  20. P Dietz, 2013, Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students, Pharmacotherapy, 33, 44, 10.1002/phar.1166 · DOI · Paper page
  21. R Ott, 2012, Neuroenhancement: perspectives of Swiss psychiatrists and general practitioners, Swiss Med Weekly, 142, w13707
  22. D Repantis, 2010, Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review, Pharmacol Res, 62, 187, 10.1016/j.phrs.2010.04.002 · DOI · Paper page
  23. DC Turner, 2003, Cognitive enhancing effects of modafinil in healthy volunteers, Psychopharmacology, 165, 260, 10.1007/s00213-002-1250-8 · DOI · Paper page
  24. MA Wulf, 2011, Das Ringen um Sinn und Anerkennung - Eine psychodynamische Sicht auf das Phänomen des Neuroenhancement (NE), Ethik in der Medizin, 24, 29, 10.1007/s00481-011-0137-9 · DOI
  25. B Partridge, 2012, Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety, Drug Alcohol Rev, 32, 295, 10.1111/dar.12005 · DOI
  26. OC Banjo, 2010, Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount, PLoS One, 5, e14322, 10.1371/journal.pone.0014322 · DOI
  27. AG Franke, 2012, What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement, PLoS One, 7, e40047, 10.1371/journal.pone.0040047 · DOI
  28. V Cakic, 2009, Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology, J Med Ethics, 35, 611, 10.1136/jme.2009.030882 · DOI · Paper page
  29. R Kühne, 2011, Der Bezug von Methylphenidat in der Schweiz: Nicht alarmierend - Fragen stellen sich dennoch, Schweizerische Ärztezeitung, 92, 1295, 10.4414/saez.2011.16235 · DOI
  30. M Bruggisser, 2011, Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets, Swiss Med Weekly, 141, w13267
  31. SP Novak, 2007, The nonmedical use of prescription ADHD medications: results from a national Internet panel, Subst Abuse Treat Prev Policy, 2, 32, 10.1186/1747-597X-2-32 · DOI
  32. I Ilieva, 2013, Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people, Neuropharmacology, 64, 496, 10.1016/j.neuropharm.2012.07.021 · DOI · Paper page
  33. BB Quednow, 2010, Neurophysiologie des Neuro-Enhancements: Möglichkeiten Möglichkeiten und Grenzen, SuchtMagazin, 36, 19
  34. AG Franke, 2012, [Characteristics of university students using stimulants for cognitive enhancement: a pilot study], Psychiatr Praxis, 39, 174
  35. M Bruggisser, 2012, Methylphenidate misuse, Praxis, 101, 299
  36. S Bell, 2013, Australian university students' attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance, Neuroethics, 6, 197, 10.1007/s12152-012-9153-9 · DOI

Cited by

See all 198

Metadata

Authors
Maier, L. J., Liechti, M. E., Herzig, F., & Schaub, M. P.
Venue
PLoS ONE
Published
2013-11-13
Volume
8
Issue
11
Pages
e77967
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2168569741
Cited by
198
References
2
FWCI
7.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students. https://app.cochat.ai/papers/10.1371/journal.pone.0077967
The paper
Maier, L. J., Liechti, M. E., Herzig, F., & Schaub, M. P. (2013). To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students. PLoS ONE. https://doi.org/10.1371/journal.pone.0077967

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.